SCHEMBL5813644

SCHEMBL5813644

CNc1nc(-c2cccc(Cl)c2)c(-c2ccnc([C@@](C)(N)c3ccccc3)n2)s1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 7/20 0.47
CDK9 P50750 7/20 0.47
KDM1A O60341 2/20 0.43
TGFBR1 P36897 1/20 0.42
BRAF P15056 2/20 0.38
MAPK14 Q16539 1/20 0.38
ADORA1 P30542 2/20 0.37
CDK2 P24941 7/20 0.37
CDK4 P11802 3/20 0.37
CDK1 P06493 5/20 0.36
CCNB1 P14635 5/20 0.36
CCNA2 P20248 5/20 0.36
CDK7 P50613 5/20 0.36
CCNH P51946 5/20 0.36
CCNA1 P78396 5/20 0.36
PLK1 P53350 1/20 0.36
ROCK1 Q13464 1/20 0.36
KMO O15229 1/20 0.35
ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5819799 0.83 CCNT1 (0.45) CCNT1CDK9TGFBR1BRAF
SCHEMBL5812487 0.82 ADORA2A (0.39) TGFBR1MAPK14ADORA1CDK2CDK4
SCHEMBL5820628 0.79 KCNH2 (0.46)
SCHEMBL5820844 0.79 KCNH2 (0.41) TGFBR1MAPK14
SCHEMBL5818662 0.79 KCNH2 (0.44) MAPK14
SCHEMBL5813647 0.78 CCNT1 (0.51) CCNT1CDK9KDM1AMAPK14PLK1
SCHEMBL5813651 0.78 CCNT1 (0.51) CCNT1CDK9KDM1AMAPK14PLK1
SCHEMBL5818966 0.78 KDM1A (0.45) CCNT1CDK9KDM1ATGFBR1MAPK14
SCHEMBL5817779 0.75 ADORA1 (0.52) CCNT1CDK9BRAFMAPK14ADORA1
SCHEMBL5817783 0.75 CCNT1 (0.43) CCNT1CDK9KDM1ATGFBR1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed